Skip to content

The effective dose of prophylactic application of metaraminol to prevent hypotension induced by combined spinal-epidural anesthesia during elective cesarean section

The effective dose of prophylactic application of metaraminol to prevent hypotension induced by combined spinal-epidural anesthesia during elective cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105124
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-07-10
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-spinal anesthesia hypotension

Interventions

Norepinephrine Group:Prophylactic application of norepinephrine
Metaraminol Group:Prophylactic application of metaraminol

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Undergo elective cesarean section under combined spinal-epidural anesthesia; 2.Age between 18 and 45 years old; 3.Singleton pregnancy at term; 4.The American Society of Anesthesiologists (ASA) physical status classification is Grade I-II.

Exclusion criteria

Exclusion criteria: 1.History of chronic hypertension or hypertensive disorders during pregnancy; 2.Those who cannot undergo intraspinal anesthesia due to contraindications; 3.Abnormal fetal development; 4.Known allergy to norepinephrine or metaraminol; 5.Refusal to participate in the study.

Design outcomes

Primary

MeasureTime frame
The ED50 of prophylactic norepinephrine bolus for preventing hypotension after combined spinal - epidural anesthesia;The ED50 of prophylactic metaraminol bolus for preventing hypotension after combined spinal - epidural anesthesia;

Secondary

MeasureTime frame
The incidence rates of hypotension, hypertension, nausea and vomiting, and bradycardia;The Apgar scores of the newborns at 1 minute, 5 minutes and 10 minutes;Umbilical artery blood gas analysis;Changes in hemodynamic data (systolic blood pressure (SBP), heart rate (HR), cardiac output (CO), stroke volume (SV), systemic vascular resistance (SVR));The time interval from the intrathecal injection of ropivacaine to the delivery of the fetus;

Countries

China

Contacts

Public ContactXu Guanghong/Chen Xixi

The First Affiliated Hospital of Anhui Medical University

xuguanghong2004@163.com+86 138 5694 9535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026